SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-170837
Filing Date
2017-05-15
Accepted
2017-05-15 17:15:33
Documents
6
Effectiveness Date
2017-05-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d392509ddefa14a.htm DEFA14A 35283
2 GRAPHIC g392509naaarrow.jpg GRAPHIC 2982
3 GRAPHIC g392509naapg01.jpg GRAPHIC 1246
4 GRAPHIC g392509naapg02.jpg GRAPHIC 1336
5 GRAPHIC g392509naapg03.jpg GRAPHIC 1275
6 GRAPHIC g392509naapg04.jpg GRAPHIC 1219
  Complete submission text file 0001193125-17-170837.txt   48300
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36483 | Film No.: 17845796
SIC: 8071 Services-Medical Laboratories